The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

BACKGROUND: Several classification systems are available to assess pathological response to neoadjuvant chemotherapy in breast cancer, but reliable biomarkers to predict the efficiency of primary systemic therapy (PST) are still missing. Deregulation of gap junction channel forming connexins (Cx) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Teleki, Ivett, Krenacs, Tibor, Szasz, Marcell A, Kulka, Janina, Wichmann, Barna, Leo, Cornelia, Papassotiropoulos, Barbel, Riemenschnitter, Cosima, Moch, Holger, Varga, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583680/
https://www.ncbi.nlm.nih.gov/pubmed/23374644
http://dx.doi.org/10.1186/1471-2407-13-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583680/
https://www.ncbi.nlm.nih.gov/pubmed/23374644
http://dx.doi.org/10.1186/1471-2407-13-50

Ejemplares similares